Cannabis Legalization in Germany: Exploring the History & New Laws

Stylized image for article on cannabis legalization in Germany
In a groundbreaking move, Germany recently emerged as the largest country in the European Union to legalize cannabis for recreational purposes for adult use purposes. This landmark decision marks a significant victory for cannabis advocates and German citizens, who have long called for regulated access to the plant. While Germany had previously permitted medicalcannabis use under tight regulations, the recent shift represents a new chapter in cannabis policy reform across Europe.
STIIIZY proudly supports progress toward the comprehensive legalization of cannabis in the U.S. and abroad. Germany's move toward regulated access and legal home cultivation demonstrates growing international momentum in cannabis reform.

The History of Cannabis in Germany

Germany's cannabis narrative is shaped by a mix of cultural legacy and modern regulation. Archaeological findings suggest that hemp and cannabis use in Central Germany dates back to 5500 BCE, with cannabis seeds discovered in funerary urns near Wilmersdorf. This underscores the region's ancient relationship with the plant.

Marijuana Medicine: A World Tour of the Healing and Visionary Powers of Cannabis By Christian Rätsch

In the 20th century, cannabis prohibition in Germany began under the Opium Act of 1929, influenced by international narcotics conventions. The plant was classified as an illicit substance, setting the tone for restrictive policies that followed.

During the 1960s and 70s, Germany experienced a wave of counterculture activism. Cannabis became a symbol of civil resistance and self-expression. These social movements laid the groundwork for public discourse around decriminalization and policy change, which intensified through the 2000s.

Germany's Medical Cannabis Program 

In March 2017, Germany introduced the "Cannabis as Medicine" program, allowing regulated access to cannabis-based products for patients with serious conditions and limited treatment options. This legislative shift acknowledged the growing public interest in cannabis-based therapies, while implementing strict controls.

Under this framework, licensed medical cannabis patients may obtain products such as dried flower, cannabis extracts, and regulated cannabinoid-based pharmaceutical preparations. Only physicians can prescribe these products, and pharmacies are authorized to distribute them. Over time, this program has expanded patient access and established a foundation for broader cannabis reform.

Cannabis farmers inspects cannabis plant

Recreational Cannabis Legalization in Germany

Starting July 1, 2024, adults aged 18 and older in Germany will be able to legally purchase and possess cannabis through regulated nonprofit clubs. Each club is capped at 500 private members and operates on a consumption-based membership fee structure. Individuals may obtain up to 25 grams per day and a maximum of 50 grams per month. For members under 21, the limit is 30 grams per month.

Cannabis possession is now legal for adults up to 25 grams, and residents may cultivate up to three plants at home. Public consumption is allowed, except within 100 meters of schools and playgrounds. These measures aim to reduce illicit market reliance while encouraging responsible access.

Germany's legalization framework also includes an amnesty provision for individuals previously convicted of cannabis-related offenses that are no longer deemed illegal. These cases are eligible for review and, in many instances, expungement, though courts may face backlogs due to the volume of applications.

Despite opposition from some political parties and legal scholars, the legislation passed under Chancellor Olaf Scholz's coalition government, which includes the Social Democrats, the Greens, and the Free Democrats.

CBD in Berlin and Across Germany 

CBD products are legally available in Germany provided they contain less than 0.2% THC, in line with European Union regulations. This has contributed to a growing CBD market, particularly in urban centers like Berlin, where CBD-infused products such as oils, capsules, cosmetics, and beverages are widely accessible.

These products are typically sold in specialized retail shops, pharmacies, and even some convenience stores. Berlin's progressive retail culture and consumer interest in plant-derived wellness products have contributed to a broad range of available CBD formats.

Stylized image of cannabis legalization in Europe

Cannabis Legalization Across Europe 

Germany's legalization efforts reflect a broader shift in cannabis policy throughout Europe. Several countries have implemented adult-use or medical cannabis programs with varying degrees of accessibility and regulation.

Malta became the first EU country to legalize adult-use cannabis in 2021, permitting personal possession and home cultivation through non-profit cooperatives. Luxembourg followed in 2023, legalizing limited personal possession and home grows. Switzerland, while not part of the EU, has launched pilot programs in major cities to explore regulated sales.

The Netherlands, known for its cannabis coffee shop model, launched the Wietexperiment in December 2023, introducing legal supply chains to select retailers. These pilots aim to shift from tolerance-based systems to fully regulated markets.

Cannabis remains the most widely used illicit substance in Europe, with an estimated market value of EUR 11.4 billion, according to the European Monitoring Centre for Drugs and Drug Addiction. As more nations consider legalization frameworks, the regional landscape continues to evolve.

Summary of Germany's Legalization Law

  • Adults aged 18+ may legally possess up to 25 grams of cannabis

  • Legal sales occur through nonprofit cannabis clubs with a 500-member limit

  • Daily purchase limit: 25 grams

  • Monthly limit: 50 grams (30 grams for those under 21)

  • Up to three plants may be grown at home

  • Public consumption is permitted but not within 100 meters of schools or playgrounds

  • Past criminal records may be reviewed or expunged under the new law

STIIIZY and the Future of Global Cannabis Reform 

Germany's adult-use cannabis legalization represents a milestone in the international shift toward regulated access. As the largest country in the EU to adopt such measures, Germany sets a precedent for other nations evaluating similar reforms.

At STIIIZY, we believe in expanding responsible access to cannabis around the world. With global attitudes changing and policy advancing, we remain committed to supporting legalization efforts and advocating for fair and transparent cannabis regulations.

FAQs

Yes. CBD products are legal as long as they contain less than 0.2% THC in accordance with EU regulations.

Cannabis is available through nonprofit cannabis clubs beginning July 1, 2024. These are private, member-only entities rather than commercial dispensaries.

Yes. Individuals may grow up to three cannabis plants at home under the new law.

By joining a nonprofit cannabis club and paying associated membership fees, residents can access cannabis legally within regulated limits.

They are expected to open in various cities across Germany, each operating privately and capped at 500 members.


STIIIZY complies with all applicable state laws regarding the sale and marketing of cannabis products. This content is intended for adults 21+ in jurisdictions where cannabis use is legal under state law. By engaging with this material, you acknowledge that you are of legal age in your jurisdiction.

This content is for informational and educational purposes only. It is not intended to diagnose, treat, cure, or prevent any disease or medical condition. STIIIZY makes no health claims about cannabis products. Consult a licensed healthcare professional before using cannabis, especially if you are pregnant, nursing, or have a medical condition.

Cannabis products may affect individuals differently. Consume responsibly and avoid operating vehicles or machinery after use. STIIIZY disclaims all liability for any adverse effects, legal consequences, or misuse resulting from the use of our products or reliance on this content.

Cannabis laws vary by state and locality. This content does not constitute legal advice. Users are responsible for understanding and complying with their local regulations.

Statements about product effects or benefits are based on general industry knowledge and user experiences. Individual results may vary. STIIIZY does not guarantee specific outcomes.

References to third-party studies, testimonials, or external resources are provided for context only. STIIIZY does not endorse or validate these materials unless explicitly stated.

The views and opinions expressed in this blog are those of the author and do not necessarily reflect the official policy or position of STIIIZY.